Detalles de la búsqueda
1.
Comparison Between Sotorasib with Docetaxel for the Treatment of Chinese Patients with Previously Treated NSCLC with KRASG12C Mutation: A Cost-Effectiveness Analysis to Inform Drug Pricing.
Adv Ther
; 2024 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38888881
2.
Efficacy and safety of Chinese patent medicines combined with antidepressants for treatment of depression in adults: A multiple-treatment meta-analysis.
J Psychiatr Res
; 176: 205-212, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38878648
3.
[Protective effect of yixinshu capsule on myocardial ischemia reperfusion injury in rats].
Zhongguo Zhong Yao Za Zhi
; 38(12): 2005-8, 2013 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-24066601
4.
Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis.
J Infect Public Health
; 16(6): 893-900, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062164
5.
Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States.
Clin Ther
; 45(10): 965-972, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537015
6.
[In vitro dissolution of forsythin in Forsythia suspensa powder of different particle diameter].
Zhongguo Zhong Yao Za Zhi
; 37(21): 3233-5, 2012 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-23397719
7.
Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell Lung Cancer.
Front Pharmacol
; 13: 832215, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35517823
8.
Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review.
Front Pharmacol
; 13: 860109, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35496294
9.
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer.
Front Pharmacol
; 13: 881787, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35712723
10.
Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Front Pharmacol
; 13: 778505, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35222020
11.
Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis.
Clin Rheumatol
; 41(1): 63-73, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373933
12.
Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.
Pharmacoeconomics
; 40(7): 725-737, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701687
13.
First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis.
Front Oncol
; 11: 699781, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34268124
14.
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States.
Adv Ther
; 38(12): 5710-5720, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34693504
15.
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer.
PLoS One
; 16(11): e0258605, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780478
16.
Cost-Effectiveness Analysis of Adding Daratumumab to a Regimen of Bortezomib, Melphalan, and Prednisone in Newly Diagnosed Multiple Myeloma.
Adv Ther
; 38(5): 2379-2390, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770365
17.
First-Line Atezolizumab for Metastatic NSCLC with High PD-L1 Expression: A United States-Based Cost-Effectiveness Analysis.
Adv Ther
; 38(5): 2447-2457, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33821431
18.
Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese Population.
Adv Ther
; 38(5): 2571-2585, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837917
19.
Cost-Effectiveness of Nivolumab Plus Ipilimumab Combined with Two Cycles of Chemotherapy as First-Line Treatment in Advanced Non-Small Cell Lung Cancer.
Adv Ther
; 38(7): 3962-3972, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100243
20.
Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy.
Front Oncol
; 11: 743765, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858820